Citations

Clear

3485 citation(s) found for "Sy, Sarah".

Comparative Evaluation of Three Commercial Systems for Detection of High-Risk Human Papillomavirus in Cervical and Vaginal ThinPrep PreservCyt Samples and Correlation with Biopsy Results
Binnicker, Matthew J. , Pritt, Bobbi S. , Duresko, Brian J., Espy, Mark J., Grys, Thomas E. , Zarka, Matthew A., Kerr, Sarah E. , Henry, Michael , Pritt, Bobbi S , Grys, Thomas E

Mayo Clinic

Journal of Clinical Microbiology | August 14, 2014 | Volume: 52 | Issue: 10 | Pages: 3763-3768

10.1128/jcm.01928-14 | PMID 25122861 Get It

ABSTRACT Genital human papillomavirus (HPV) is the etiologic agent of more than 99% of all cervical cancers worldwide, with 14 genotypes being considered oncogenic or “high risk” because of their association with severe dysplasia and cervical carcinoma. Among these 14 high-risk types, HPV-16 and -18 account for approximately 70% of cervical cancers. The aim of this study was to evaluate three FDA-approved HPV nucleic acid-based tests for the ability to predict high-grade cervical intraepithelial neoplasias (CIN2 or worse) in corresponding tissue biopsy specimens. Residual specimens (total n = 793, cervical n = 743, vaginal n = 50) collected in ThinPrep PreservCyt medium with a cytologic result of ≥atypical squamous cells of undetermined significance were tested by the Hybrid Capture 2 (HC2) assay (Qiagen, Gaithersburg, MD), the cobas HPV test (Roche Diagnostics, Indianapolis, IN), and the APTIMA HPV assay (Hologic, San Diego, CA). Genotyping for HPV-16 and HPV-18 was simultaneously performed by the cobas HPV test. Results were compared to cervical or vaginal biopsy findings, when they were available ( n = 350). Among the 350 patients with corresponding biopsy results, 81 (23.1%) showed ≥CIN2 by histopathology. The ≥CIN2 detection sensitivity was 91.4% by the cobas and APTIMA assays and 97.5% by HC2 assay. The specificities of the cobas, APTIMA, and HC2 assays were 31.2, 42.0, and 27.1%, respectively. When considering only positive HPV-16 and/or HPV-18 genotype results, the cobas test showed a sensitivity and a specificity of 51.9 and 86.6%, respectively. While the HC2, cobas, and APTIMA assays showed similar sensitivities for the detection of ≥CIN2 lesions, the specificities of the three tests varied, with the greatest specificity (86.6%) observed when the HPV-16 and/or HPV-18 genotypes were detected.
Clinical Utility of Chromosomal Microarray Analysis of DNA from Buccal Cells: Detection of Mosaicism in Three Patients
Sdano, Mallory R., Vanzo, Rena , Martin, Megan , Baldwin, Erin E. , South, Sarah T., Rope, Alan F. , Allen, William, Kearney, Hutton M.

Mayo Clinic

Journal of Genetic Counseling | August 14, 2014 | Volume: 23 | Issue: 6 | Pages: 922-927

10.1007/s10897-014-9751-2 | PMID 25120037 Get It

AbstractMosaic chromosomal abnormalities are relatively common. However, mosaicism may be missed due to multiple factors including failure to recognize clinical indications and order appropriate testing, technical limitations of diagnostic assays, or sampling tissue (s) in which mosaicism is either not present, or present at very low levels. Blood leukocytes have long been the “gold standard” sample for cytogenetic analysis; however, the culturing process for routine chromosome analysis can complicate detection of mosaicism since the normal cell line may have a growth advantage in culture, or may not be present in the cells that produce metaphases (the lymphocytes). Buccal cells are becoming increasingly utilized for clinical analyses and are proving to have many advantages. Buccal swabs allow for simple and noninvasive DNA collection. When coupled with a chromosomal microarray that contains single nucleotide polymorphic probes, analysis of buccal cells can maximize a clinician's opportunity to detect cytogenetic mosaicism. We present three cases of improved diagnosis of mosaic aberrations using buccal specimens for chromosomal microarray analysis. In each case, the aberration was either undetectable in blood or present at such a low level it likely could have gone undetected. These cases highlight the limitations of certain laboratory methodologies for identifying mosaicism. We also present practice implications for genetic counselors, including clinic workflow changes and counseling approaches based on increasing use of buccal samples.
Re: Sarcopenia as a Predictor of Complications and Survival Following Radical Cystectomy
Psutka, Sarah P. , Moynagh, Michael R., Schmit, Grant D. , Tollefson, Matthew K. , Moynagh, Michael, Schmit, Grant, Psutka, Sarah P

Mayo Clinic

Journal of Urology | August 8, 2014 | Volume: 192 | Issue: 5 | Pages: 1582-1583

10.1016/j.juro.2014.05.104 | PMID 25111530 Get It

Ataxic Dysarthria
Kent, Ray D., Kent, Jane F., Duffy, Joe R., Thomas, Jack E., Weismer, Gary, Stuntebeck, Sarah, Duffy, Joseph R.

Mayo Clinic

Journal of Speech, Language, and Hearing Research | July 29, 2014 | Volume: 43 | Issue: 5 | Pages: 1275-1289

10.1044/jslhr.4305.1275 | PMID 11063247 Get It

Although ataxic dysarthria has been studied with various methods in several languages, questions remain concerning which features of the disorder are most consistent, which speaking tasks are most sensitive to the disorder, and whether the different speech production subsystems are uniformly affected. Perceptual and acoustic data were obtained from 14 individuals (seven men, seven women) with ataxic dysarthria for several speaking tasks, including sustained vowel phonation, syllable repetition, sentence recitation, and conversation. Multidimensional acoustic analyses of sustained vowel phonation showed that the largest and most frequent abnormality for both men and women was a long-term variability of fundamental frequency. Other measures with a high frequency of abnormality were shimmer and peak amplitude variation (for both sexes) and jitter (for women). Syllable alternating motion rate (AMR) was typically slow and irregular in its temporal pattern. In addition, the energy maxima and minima often were highly variable across repeated syllables, and this variability is thought to reflect poorly coordinated respiratory function and inadequate articulatory/voicing control. Syllable rates tended to be slower for sentence recitation and conversation than for AMR, but the three rates were highly similar. Formant-frequency ranges during sentence production were essentially normal, showing that articulatory hypometria is not a pervasive problem. Conversational samples varied considerably across subjects in intelligibility and number of words/ morphemes in a breath group. Qualitative analyses of unintelligible episodes in conversation showed that these samples generally had a fairly well-defined syllable pattern but subjects differed in the degree to which the acoustic contrasts typical of consonant and vowel sequences were maintained. For some individuals, an intelligibility deficit occurred in the face of highly distinctive (and contrastive) acoustic patterns.
Factors Associated with Adherence to an End-of-Study Biopsy: Lessons from the Prostate Cancer Prevention Trial (SWOG-Coordinated Intergroup Study S9217)
Gritz, Ellen R., Arnold, Kathryn B. , Moinpour, Carol M. , Burton‐Chase, Allison M. , Probstfield, Jeffrey F., See, William A., Lieber, Michael M., Caggiano, Vincent , Moody‐Thomas, Sarah, Szczepanek, Connie M. , Ryan, Anne, Carlin, Susie M., Hill, Shannon , Goodman, Phyllis J. , Padberg, Rose Mary, Minasian, Lori M. , Meyskens, Frank L. , Thompson, Ian M. , Tangen, Catherine M. , Thompson, Ian M

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | July 16, 2014 | Volume: 23 | Issue: 8 | Pages: 1638-1648

10.1158/1055-9965.epi-14-0202 | PMID 25028457 Get It

Abstract Background: The Prostate Cancer Prevention Trial (PCPT) was a 7-year randomized, double-blind, placebo-controlled trial of the efficacy of finasteride for the prevention of prostate cancer with a primary outcome of histologically determined prevalence of prostate cancer at the end of 7 years. Methods: A systematic modeling process using logistic regression identified factors available at year 6 that are associated with end-of-study (EOS) biopsy adherence at year 7, stratified by whether participants were ever prompted for a prostate biopsy by year 6. Final models were evaluated for discrimination. At year 6, 13,590 men were available for analysis. Results: Participants were more likely to have the EOS biopsy if they were adherent to study visit schedules and procedures and/or were in good health (P < 0.01). Participants at larger sites and/or sites that received retention and adherence grants were also more likely to have the EOS biopsy (P < 0.05). Conclusions: Our results show good adherence to study requirements 1 year before the EOS biopsy was associated with greater odds that a participant would comply with the invasive EOS requirement. Impact: Monitoring adherence behaviors may identify participants at risk of nonadherence to more demanding study end points. Such information could help frame adherence intervention strategies in future trials. Cancer Epidemiol Biomarkers Prev; 23(8); 1638–48. ©2014 AACR.
Lung cancer adrenal gland metastasis: Optimal fine‐needle aspirate and touch preparation smear cellularity characteristics for successful theranostic next‐generation sequencing
Gleeson, Ferga C. , Kipp, Benjamin R. , Levy, Michael J. , Voss, Jesse S. , Campion, Michael B., Minot, Douglas M., Tu, Zheng Jin, Klee, Eric W. , Kerr, Sarah E. , Levy, Michael J. , Lazaridis, Konstantinos N.

Mayo Clinic

Cancer Cytopathology | July 15, 2014 | Volume: 122 | Issue: 11 | Pages: 822-832

10.1002/cncy.21464 | PMID 25045116 Get It

BACKGROUNDMultigene molecular testing to guide personalized therapy for oncology patients is of increasing clinical relevance. Molecular testing of fine‐needle aspiration samples is underused, but when acquired with minimally invasive techniques could become the standard of care to obtain theranostic specimens. The aims of the current study were to identify key cytology specimen selection criteria suitable for next‐generation sequencing (NGS) and to determine the prevalence and spectrum of pathogenic alterations in a cohort of patients with AJCC stage IV lung cancer.METHODSA total of 70 adrenal gland cytology specimens with direct smears were screened to identify 56 patients with a single slide containing at least 300 total cells and 20% tumor nuclei. After DNA extraction, the NGS protocols were used to simultaneously detect mutations in >2800 exonic regions in 50 key cancer genes.RESULTSA total of 28 specimens produced acceptable NGS results. Specimens with a combined critical cell mass (>5000 viable cells) and a DNA concentration >5 ng/µL resulted in a 95% chance of successful sequencing. A total of 37 pathogenic alterations were identified in 10 genes and in 25 patients (85%). A pathogenic alteration (≥1) linked to available or developing targeted therapies was revealed in 50% of cases.CONCLUSIONSThe data from the current study demonstrate that theranostic NGS can be applied to adrenal gland metastasis using routine cytologic smear specimens. The characteristics of such smears could be evaluated during onsite adequacy assessment by cytopathology professionals. This model greatly augments the opportunity for customized genotype‐directed therapy from minimally invasive techniques. Cancer (Cancer Cytopathol) 2014;122:822–832. © 2014 American Cancer Society.
Diabetes Mellitus is Independently Associated with an Increased Risk of Mortality in Patients with Clear Cell Renal Cell Carcinoma
Psutka, Sarah P. , Stewart, Suzanne, Boorjian, Stephen A. , Lohse, Christine M. , Tollefson, Matthew K. , Cheville, John C. , Leibovich, Bradley C. , Thompson, R. Houston, Stewart, Suzanne B, Psutka, Sarah P

Mayo Clinic

Journal of Urology | June 12, 2014 | Volume: 192 | Issue: 6 | Pages: 1620-1627

10.1016/j.juro.2014.06.014 | PMID 24931804 Get It

Black Bears With Longer Disuse (Hibernation) Periods Have Lower Femoral Osteon Population Density and Greater Mineralization and Intracortical Porosity
Wojda, Samantha J. , Weyland, David R., Gray, Sarah K., McGee‐Lawrence, Meghan E. , Drummer, Thomas D., Donahue, Seth W. , McGee-Lawrence, Meghan E

Mayo Clinic

The Anatomical Record | June 9, 2014 | Volume: 296 | Issue: 8 | Pages: 1148-1153

10.1002/ar.22720 | PMID 23728917 Get It

ABSTRACTIntracortical bone remodeling is persistent throughout life, leading to age related increases in osteon population density (OPD). Intracortical porosity also increases with age in many mammals including humans, contributing to bone fragility and fracture risk. Unbalanced bone resorption and formation during disuse (e.g., physical inactivity) also increases intracortical porosity. In contrast, hibernating bears are a naturally occurring model for the prevention of both age‐related and disuse osteoporoses. Intracortical bone remodeling is decreased during hibernation, but resorption and formation remain balanced. Black bears spend 0.25–7 months in hibernation annually depending on climate and food availability. We found longer hibernating bears demonstrate lower OPD and higher cortical bone mineralization than bears with shorter hibernation durations, but we surprisingly found longer hibernating bears had higher intracortical porosity. However, bears from three different latitudes showed age‐related decreases in intracortical porosity, indicating that regardless of hibernation duration, black bears do not show the disuse‐ or age‐related increases in intracortical porosity which is typical of other animals. This ability to prevent increases in intracortical porosity likely contributes to their ability to maintain bone strength during prolonged periods of physical inactivity and throughout life. Improving our understanding of the unique bone metabolism in hibernating bears will potentially increase our ability to develop treatments for age‐ and disuse‐related osteoporoses in humans. Anat Rec, 2013. © 2013 Wiley Periodicals, Inc.
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
Castellar, Edgardo R. Parrilla , Jaffe, Elaine S. , Said, Jonathan , Ketterling, Rhett P. , Knudson, Ryan A., Sidhu, Jagmohan S. , Karikehalli, Shridevi, Jiang, Liuyan , Vasmatzis, George , Ondrejka, Sarah L. , Nicolae, Alina , Grogg, Karen L., Allmer, Cristine, Ristow, Kay M., Wilson, Wyndham H. , Macon, William R. , Cerhan, James R. , Ansell, Stephen M. , Maurer, Matthew J. , Feldman, Andrew L. , Parrilla Castellar, Edgardo R, Law, Mark E. , Doǧan, Ahmet , Feldman, Andrew L , Swerdlow, Steven H. , Hsi, Eric D. , Gibson, Sarah E. , Habermann, Thomas M. , Maurer, Matthew , Cerhan, James R , Jaffe, Elaine S , Ketterling, Rhett P

Mayo Clinic

Blood | June 3, 2014 | Volume: 124 | Issue: 9 | Pages: 1473-1480

10.1182/blood-2014-04-571091 | PMID 24894770 Get It

Key Points ALK-negative ALCLs have chromosomal rearrangements of DUSP22 or TP63 in 30% and 8% of cases, respectively. DUSP22-rearranged cases have favorable outcomes similar to ALK-positive ALCLs, whereas other genetic subtypes have inferior outcomes.